戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ants, such as the peptide N-formyl-methionyl-leucyl-phenylalanine.
2 myristate acetate (PMA) and formyl-methionyl-leucyl-phenylalanine.
3 tase after stimulation with formyl-methionyl-leucyl-phenylalanine.
4 ence of the chemoattractant formyl-methionyl-leucyl-phenylalanine.
5 er muscle in response to N-formyl- methionyl-leucyl-phenylalanine.
6  and after stimulation with formyl-methionyl-leucyl-phenylalanine (100 nM).
7  surface of unactivated and formyl methionyl leucyl phenylalanine-activated PMN as determined by indi
8             We found that N-formyl-methionyl-leucyl-phenylalanine, an FPR agonist peptide, rapidly in
9 ses upon stimulation with N-formyl methionyl leucyl phenylalanine and CC chemokine ligand (CCL) 3 (ne
10 multaneously treated with N-formyl-methionyl-leucyl-phenylalanine and IgE plus polyvalent antigen.
11 ogically relevant agents, N-formyl-methionyl-leucyl-phenylalanine and leukotriene B4, by approximatel
12 tants interleukin 8, C5a, N-formyl-methionyl-leucyl-phenylalanine, and interleukin 15, adhesion molec
13 ads, Staphylococcus aureus, formyl-methionyl-leucyl-phenylalanine, and zymosan were reduced by approx
14 activity and adhesiveness of formylmethionyl-leucyl-phenylalanine- and arachidonic acid-stimulated ne
15 or necrosis factor (TNF) or formyl-methionyl-leucyl-phenylalanine, as described for human PMNs.
16  of the chemotactic peptide formyl-methionyl-leucyl-phenylalanine at 10(-10)-10(-8) M and to the chem
17 CAM-1, and stimulation with formyl-methionyl-leucyl-phenylalanine boosted capture efficiency through
18 non-fluorescent peptide ligand CHO-methionyl-leucyl-phenylalanine (CHO-MLF).
19 ammatory process induced by formyl-methionyl-leucyl-phenylalanine exposure.
20 ng the transmucosal flux of formyl-methionyl-leucyl-phenylalanine (f-MLP), a ubiquitous neutrophilic
21 neutrophil stimulation with formyl-methionyl-leucyl-phenylalanine, FcgammaR cross-linking, or phospha
22 s significantly increased N-formyl-methionyl-leucyl phenylalanine (fMLF)-stimulated superoxide releas
23  the plasma membrane upon N-formyl-methionyl-leucyl-phenylalanine (fMLF) stimulation and colocalizes
24 licited by phorbol ester or formyl-methionyl-leucyl-phenylalanine (fMLF) was unaffected.
25                             Formyl methionyl leucyl phenylalanine (fMLP) stimulates neutrophils to ad
26 ly 10-fold in response to N-formyl methionyl leucyl phenylalanine (fMLP).
27 nd ex vivo perfusion with n-formyl-methionyl-leucyl-phenylalanine (fMLP) (10(-)(7) M).
28 PMN chemotactic responses to formylmethionyl-leucyl-phenylalanine (fMLP) and IL-8 were dose-dependent
29 neutrophils, which binds to formyl-methionyl-leucyl-phenylalanine (fMLP) and plays a role in neutroph
30  and elastase) exposed to N-formyl-methionyl-leucyl-phenylalanine (fMLP) and/or multivalent immune co
31  of the chemotactic peptide formyl-methionyl-leucyl-phenylalanine (fMLP) caused a dose-dependent (10(
32 state 13-alpha-acetate or N-formyl methionyl-leucyl-phenylalanine (fMLP) for stimulus.
33  cells were exposed to an N-formyl-methionyl-leucyl-phenylalanine (FMLP) gradient whose source was pe
34 chemoattractant signal of N-formyl-methionyl-leucyl-phenylalanine (FMLP) in the absence of a spatial
35 his paradigm, we injected N-formyl-methionyl-leucyl-phenylalanine (FMLP) intradermally in guinea pigs
36 e primary chemoattractant N--formylmethionyl-leucyl-phenylalanine (fMLP) is mediated by leukotriene B
37           Microinjection of formyl-methionyl-leucyl-phenylalanine (fMLP) or macrophage inflammatory p
38 n secondary activation by N-formyl-methionyl-leucyl-phenylalanine (FMLP) or phorbol myristate acetate
39                             Formyl-methionyl-leucyl-phenylalanine (FMLP) rapidly and transiently acti
40 ed human neutrophils with N-formyl-methionyl-leucyl-phenylalanine (fMLP) results in biphasic activati
41         The chemoattractant formyl-methionyl-leucyl-phenylalanine (fMLP) stimulated p38-MAPK-dependen
42  followed by treatment with formyl-methionyl-leucyl-phenylalanine (fMLP) stimulates cells in a physio
43                             Formyl-methionyl-leucyl-phenylalanine (FMLP) stimulation (10(-7) M) resul
44 e assessed in response to N-formyl-methionyl-leucyl-phenylalanine (fMLP) stimulation.
45 rom cells with or without N-formylmethionine leucyl-phenylalanine (fMLP) stimulation.
46 lation of PMNs with 1 muM N-formyl-methionyl-leucyl-phenylalanine (fMLP) triggered earlier and more s
47 -8), formylpeptides (e.g. N-formyl-methionyl-leucyl-phenylalanine (fMLP)), and platelet-activating fa
48 ing N-formylated peptide (N-formyl-methionyl-leucyl-phenylalanine (fMLP)), platelet activating factor
49 coincubated with 0.5 microM formyl-methionyl-leucyl-phenylalanine (fMLP), 1.3 microM 22:6OOH, or 5.0
50 lls permits absorption of N-formyl-methionyl-leucyl-phenylalanine (fMLP), as occurs in hPepT1 express
51 ) and then activated with N-formyl-methionyl-leucyl-phenylalanine (FMLP), C(2)-ceramide (10 microM) c
52  to the chemotactic peptide formyl-methionyl-leucyl-phenylalanine (FMLP), colony stimulating factor-1
53 dition of PMN stimulants, N-formyl-methionyl-leucyl-phenylalanine (FMLP), or phorbol myristate acetat
54 neutrophils were exposed to formyl-methionyl-leucyl-phenylalanine (fMLP), PKCbetaII was rapidly phosp
55 actic bacterial peptide, N-formyl- methionyl-leucyl-phenylalanine (fMLP), was able to specifically at
56 CNS, and also reduces the N-formyl-methionyl-leucyl-phenylalanine (fMLP)-induced neutrophil respirato
57  examine the mechanism of N-formyl-methionyl-leucyl-phenylalanine (fMLP)-mediated formation of CysLT.
58 ion of FPRwt reconstituted N-formylmethionyl-leucyl-phenylalanine (FMLP)-stimulated extracellular sig
59       Our results show that formyl-methionyl-leucyl-phenylalanine (fMLP)-stimulated respiratory burst
60 polysaccharide (LPS)- and N-formyl-methionyl-leucyl-phenylalanine (FMLP)-stimulated U937 adhesion to
61 d their chemotaxis toward N-formyl-methionyl-leucyl-phenylalanine (FMLP).
62  bacterial chemoattractant, formyl-methionyl-leucyl-phenylalanine (fMLP).
63 ted upon stimulation with N-formyl-methionyl-leucyl-phenylalanine (fMLP).
64 with LPS, RPMI alone, and N formyl-methionyl-leucyl-phenylalanine (FMLP).
65 lammatory stimuli such as N-formyl-methionyl-leucyl-phenylalanine (fMLP).
66 ponse to the formyl peptide formyl-norleucyl-leucyl-phenylalanine (fNLLP).
67 e, opsonized zymosan, and N-formyl-methionyl-leucyl-phenylalanine) induce p22(phox) phosphorylation i
68 atelet-activating factor or formyl-methionyl-leucyl-phenylalanine induced beta(2)-integrin-dependent
69 bolish the TNF-alpha- and N-formyl-methionyl-leucyl-phenylalanine-induced activation of acetyltransfe
70       Since the kinetics of formyl-methionyl-leucyl-phenylalanine-induced F-actin response were highl
71  quantitative analysis of N-formyl-methionyl-leucyl-phenylalanine-induced increase in binding of (35)
72 icient in spontaneous and N-formyl-methionyl-leucyl-phenylalanine-induced polarization, 0.5 microM pe
73 ine before stimulation with formyl methionyl-leucyl-phenylalanine inhibited A3 receptor expression an
74 nse to multiple agonists (N-formyl-methionyl-leucyl-phenylalanine, interleukin-8, and C5a).
75 ntact cells stimulated with formyl-methionyl-leucyl-phenylalanine, intermediate filament assembly is
76 s activated to secrete with formyl-methionyl-leucyl-phenylalanine, intermediate filaments are phospho
77 peptide receptor agonist (N-formyl-methionyl-leucyl-phenylalanine-lysine; N-For-MLFK) were compared w
78 phils under conditions of N-formyl-methionyl-leucyl-phenylalanine-mediated cPLA(2)alpha activation.
79  cells were stimulated by N-formyl-methionyl-leucyl-phenylalanine or opsonized zymosan.
80 h configuration with PMA, N-formyl-methionyl-leucyl-phenylalanine, or anti-IgE greatly enhanced proto
81 bol myristate acetate (PMA), formylmethionyl-leucyl-phenylalanine, or Escherichia coli.
82 stimulated with anti-IgE, N-formyl-methionyl-leucyl-phenylalanine, or phorbol 12-myristate 13-acetate
83 hil activation induced by N-formyl-methionyl-leucyl-phenylalanine, phorbol 12-myristate 13-acetate, o
84 od extension induced with N-formyl-methionyl-leucyl-phenylalanine, platelet activating factor, and le
85 ty in cells stimulated with formyl-methionyl-leucyl phenylalanine plus dihydrocytochalasin B.
86  without the high-affinity N-formylmethionyl-leucyl-phenylalanine receptor antagonist N-tert-butoxyca
87 were assayed in vitro for N-formyl-methionyl-leucyl-phenylalanine receptor binding and superoxide pro
88 mannose receptor, and the N-formyl-methionyl-leucyl-phenylalanine receptor) did not have demonstrated
89 d doubling of the number of formyl-methionyl-leucyl-phenylalanine receptors on the cells.
90 on and O(2)(-) responses to formyl-methionyl-leucyl-phenylalanine, reflecting the same cellular pheno
91 ation, and TNFalpha-primed, formyl-methionyl-leucyl-phenylalanine-stimulated respiratory burst.
92 rachidonate production in N-formyl-methionyl-leucyl-phenylalanine-stimulated U937 cells.
93 Mbeta2 integrin following N-formyl-methionyl-leucyl phenylalanine stimulation.
94 generation before and after formyl-methionyl-leucyl-phenylalanine stimulation was significantly reduc
95 onic saline-treatment after formyl methionyl-leucyl-phenylalanine-stimulation augmented A3 receptor e
96 e-colony-stimulating factor/formyl-methionyl-leucyl-phenylalanine stimuli, which can induce eicosanoi
97 ha (TNF-alpha) as well as N-formyl-methionyl-leucyl-phenylalanine treatment leads to increased phosph
98  retains coupling between N-formyl-methionyl-leucyl-phenylalanine tripeptide (FMLP) receptor stimulat
99 eness upon stimulation with formyl-methionyl-leucyl phenylalanine was found to identify sputum eosino
100 y the chemoattractant fMLF (formyl methionyl leucyl phenylalanine) was observed by RICM (reflection i
101 by neutrophils, induced by N-formylmethionyl-leucyl-phenylalanine, was strongly inhibited by inhibito
102 otype N-formylpeptide fMLF (formyl-methionyl-leucyl-phenylalanine) were both absent in FPR-/- mice.
103  also seen in response to N-formyl-methionyl-leucyl-phenylalanine, zymosan-activated serum, or macrop

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top